NCT05702203 Creative Music Therapy in Newborns With Congenital Heart Disease
| NCT ID | NCT05702203 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Children's Hospital, Zurich |
| Condition | Congenital Heart Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2022-11-22 |
| Primary Completion | 2025-10-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2022-11-22 with a primary completion date of 2025-10-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the context of a clinical trial, the investigators will evaluate if parent-infant interaction can be improved by a family integrated, individualised, interactive resource- and needs-oriented music therapy approach in the dyads of infants with congenital heart disease and their parents. This intervention will be compared with the standard of care. Infants allocated to the control group will receive standard care during admission. Standard care includes involvement of a multi-professional team consisting of medical and nursing team, psychologists/psychiatrists, social workers, breastfeeding counsellor, speech therapist, nutritional counsellor and physiotherapists.
Eligibility Criteria
Inclusion Criteria: * All newborn infants with CHD born \>35 weeks of gestational and \<28 days at diagnosis of CHD irrespective of severity of the heart disease * Admitted to Neonatal Intensiv Care Unit/Pediatric Intensiv Care Unit (NICU/PICU) at the Children's University Hospital * Infants with syndromes and /or confirmed chromosomal abnormalities Exclusion Criteria: \- Gestational age at birth \<35 weeks, age \>28 days at diagnosis of CHD
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05702203 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, up to 28 Days, studying Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05702203 currently recruiting?
Yes, NCT05702203 is actively recruiting participants. Contact the research team at cornelia.hagmann@kispi.uzh.ch for enrollment information.
Where is the NCT05702203 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT05702203 clinical trial?
NCT05702203 is sponsored by University Children's Hospital, Zurich. The trial plans to enroll 164 participants.